LymphoTrack® Archives

Cat #: 71220007
LymphoTrack^® IGK Assay – S5/PGM™
The human immunoglobulin kappa light chain (IGK) gene locus on chromosome 2 (2p11.2) includes many distinct Vϰ gene segments, grouped into seven Vϰ ...
View Product
Cat #: 71220009
LymphoTrack^® IGK Assay Kit A – MiSeq^TM
The human immunoglobulin kappa light chain (IGK) gene locus on chromosome 2 (2p11.2) includes many distinct Vϰ gene segments, grouped into seven Vϰ ...
View Product
Cat #: 71220019
LymphoTrack^® IGK Assay Panel – MiSeq^TM
The human immunoglobulin kappa light chain (IGK) gene locus on chromosome 2 (2p11.2) includes many distinct Vϰ gene segments, grouped into seven Vϰ ...
View Product
Cat #: 72270007
LymphoTrack^® TRG Assay – S5/PGM™
This LymphoTrack TRG Assay – S5/PGM represents a significant improvement over existing clonality assays using fragment analysis as it efficiently d...
View Product
Cat #: 72270019
LymphoTrack^® TRG Assay Kit A – MiSeq^TM
This LymphoTrack TRG Assay – MiSeq represents a significant improvement over existing clonality assays using fragment analysis as it efficient...
View Product
Cat #: 72270009
LymphoTrack^® TRG Assay Panel – MiSeq^TM
This LymphoTrack TRG Assay – MiSeq represents a significant improvement over existing clonality assays using fragment analysis as it efficient...
View Product
Cat #: 75000008
LymphoTrack^® MRD Software
For a Sequence Detected result, the software will report the number of reads and cumulative frequencies of exact sequence matches and similar sequence...
View Product
Cat #: 75000009
LymphoTrack^® Software – MiSeq^®
The LymphoTrack® Assays – MiSeq® were designed to produce sequencing data that can be analyzed using the LymphoTrack® Software – MiSe...
View Product
Cat #: 75000007
LymphoTrack^® Software – S5/PGM^™
The LymphoTrack® Assays – S5/PGM™ were designed to produce sequencing data that can be analyzed using the LymphoTrack® Software – S5/PGM�...
View Product
Cat #: 72250009
LymphoTrack^® TRB Assay Kit A – MiSeq^TM
This LymphoTrack TRB Assay – MiSeq represents a significant improvement over existing clonality assays using fragment analysis as it efficiently d...
View Product
Cat #: 72250019
LymphoTrack^® TRB Assay Panel – MiSeq^TM
This LymphoTrack TRB Assay – MiSeq represents a significant improvement over existing clonality assays using fragment analysis as it efficiently d...
View Product
Cat #: 71210007
LymphoTrack^® IGH FR1 Assay – S5/PGM™
This LymphoTrack IGH FR1 Assay – S5/PGM represents a significant improvement over existing clonality assays using fragment analysis as it efficient...
View Product
Cat #: 71210009
LymphoTrack^® IGH FR1 Assay Kit A – MiSeq^TM
This LymphoTrack IGH Assay – MiSeq represents a significant improvement over existing clonality assays using fragment size analysis as it efficientl...
View Product
Cat #: 71210129
LymphoTrack^® IGH FR1/2/3 Assay Kit A – MiSeq^TM
The LymphoTrack IGH FR1/2/3 Assay for MiSeq represent a significant improvement over existing clonality assays using fragment analysis as they efficie...
View Product
Cat #: 71210039
LymphoTrack^® IGH FR1 Assay Panel – MiSeq^TM
This LymphoTrack IGH Assay – MiSeq represents a significant improvement over existing clonality assays using fragment size analysis as it efficientl...
View Product
Cat #: 71210057
LymphoTrack^® IGH FR1/2/3 Assay – S5/PGM™
The LymphoTrack IGH FR1/2/3 Assay for the Ion S5 and PGM represents a significant improvement over existing clonality assays using fragment analysis...
View Product
Cat #: 71210139
LymphoTrack^® IGH FR1/2/3 Assay Panel – MiSeq^TM
The LymphoTrack IGH FR1/2/3 Assay for MiSeq represent a significant improvement over existing clonality assays using fragment analysis as they efficie...
View Product
Cat #: 71210037
LymphoTrack^® IGH FR2 Assay – S5/PGM™
The LymphoTrack IGH FR2 Assay for the Ion PGM represents a significant improvement over existing clonality assays using fragment analysis as they ef...
View Product
Cat #: 71210089
LymphoTrack^® IGH FR2 Assay Kit A – MiSeq^TM
This LymphoTrack IGH Assay – MiSeq represents a significant improvement over existing clonality assays using fragment size analysis as it efficientl...
View Product
Cat #: 71210099
LymphoTrack^® IGH FR2 Assay Panel – MiSeq^TM
This LymphoTrack IGH Assay – MiSeq represents a significant improvement over existing clonality assays using fragment size analysis as it efficientl...
View Product
Cat #: 71210119
LymphoTrack^® IGH FR3 Assay Panel – MiSeq^TM
This LymphoTrack IGH Assay – MiSeq represents a significant improvement over existing clonality assays using fragment size analysis as it efficientl...
View Product
Cat #: 71210109
LymphoTrack^® IGH FR3 Assay Kit A – MiSeq^TM
This LymphoTrack IGH Assay – MiSeq represents a significant improvement over existing clonality assays using fragment size analysis as it efficientl...
View Product
Cat #: 71210047
LymphoTrack^® IGH FR3 Assay – S5/PGM™
The LymphoTrack IGH FR3 Assay for the Ion S5/PGM represents a significant improvement over existing clonality assays using fragment analysis as they...
View Product
Cat #: 71210059
LymphoTrack^® IGHV Leader Somatic Hypermutation Assay Kit A – MiSeq^TM
This LymphoTrack IGHV Leader Somatic Hypermutation Assay – MiSeq represents a significant improvement over existing clonality assays using fragmen...
View Product
Cat #: 71210069
LymphoTrack^® IGHV Leader Somatic Hypermutation Assay Panel – MiSeq^TM
This LymphoTrack IGHV Leader Somatic Hypermutation Assay – MiSeq represents a significant improvement over existing clonality assays using fragmen...
View Product
Cat #: 71210149
LymphoTrack^® IGH FR1 Assay Panel B – MiSeq^TM
This LymphoTrack IGH Assay – MiSeq represents a significant improvement over existing clonality assays using fragment size analysis as it efficientl...
View Product
Cat #: 40880098
LymphoTrack^® B-cell Low Positive Control
Minimal Residual Disease (MRD) testing by Next-Generation Sequencing (NGS) is a proven tool in the development of management strategies for hematologi...
View Product
Cat #: 40880118
LymphoQuant^® B-cell Internal Control
LymphoQuant B-cell Internal Controls may be spiked into specimens to estimate the respective number of IGH clonotype equivalents present. Addition o...
View Product
Cat #: 40880128
LymphoQuant^® T-Cell Internal Control
The T-cell LymphoQuant Internal Control and T-cell LymphoTrack Low Positive Control are utilized in controlled MRD studies of TRG and TRB gene rearran...
View Product
Cat #: 40880108
LymphoTrack^® T-Cell Low Positive Control
The T-cell LymphoQuant Internal Control and T-cell LymphoTrack Low Positive Control are utilized in controlled MRD studies of TRG and TRB gene rearran...
View Product
Cat #: S100003
LymphoTrack^® Enterprise Software
The LymphoTrack Enterprise Software package was designed to enable pipeline automation for high-throughput sequencing laboratories using LymphoTrack A...
View Product

Now Available

Our New Document Search Feature

SEARCH ⟶

Need Help Placing an Online Order?

Contact our Customer Service Team

CONTACT CUSTOMER SERVICE ⟶

Now Available

Our New Document Search Feature

SEARCH ⟶

Need Help Placing an Online Order?

Contact our Customer Service Team

CONTACT CUSTOMER SERVICE ⟶

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021 Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Now Available

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

April 20th, 2021
Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing